Augmedix Exits Calendar 2023 with Expected $51 Million in Annual Recurring Revenue
SAN FRANCISCO, Jan. 05, 2024 (GLOBE NEWSWIRE) — Augmedix, Inc. (Nasdaq:AUGX), a healthcare technology company that delivers industry-leading ambient medical documentation and data solutions, today announced preliminary revenue results and operational metrics for the fourth quarter of 2023.
Related news for (AUGX)
- Commure to Acquire Augmedix
- Augmedix Announces Participation in Maxim Group Virtual Healthcare IT Investor Conference
- Augmedix Partners with Google Cloud to Bring Medically-Tuned AI Technology to Ambient Documentation
- Augmedix Partners with Google Cloud to Bring Medically-Tuned AI Technology to Ambient Documentation